menu search

protara therapeutics announces third quarter 2023 financial results and business update

Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24 Company initiat...

November 3, 2023, 12:00 pm

protara therapeutics announces positive preliminary data from advanced-1 phase 1a dose escalation trial of tara-002 in nmibc supporting advancement into phase 2 clinical development

Favorable tolerability observed in patients with NMIBC treated with TARA-002 in ADVANCED-1 trial Anti-tumor activity was observed in all three evaluab...

April 28, 2023, 12:00 pm

Can protara therapeutics (tara) climb 680% to reach the level wall street analysts expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 680.4% in protara...

April 11, 2022, 11:17 am


Search within

Pages Search Results: